# Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

> **NCT00804622** · PHASE2 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 15 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** telbivudine
- **DRUG:** tenofovir disproxil fumarate
- **DRUG:** telbivudine plus tenofovir disproxil fumarate

## Key facts

- **NCT ID:** NCT00804622
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2010-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804622, "Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00804622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*